PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease.

Matis, S; Mariani, M R; Cutrona, G; Cilli, M; Piccardi, F; Daga, A; Damonte, G; Millo, E; Moroni, M; Roncella, S; Fedeli, F; Boffa, L C; Ferrarini, M

Matis, S; Mariani, M R; Cutrona, G; Cilli, M; Piccardi, F; Daga, A; Damonte, G; Millo, E; Moroni, M; Roncella, S; Fedeli, F; Boffa, L C; Ferrarini, M.

Affiliation

Matis S; S.C. Oncologia Medica C, Istituto Nazionale per la Ricerca sul Cancro, IST, 16132 Genova, Italy.

Cancer Gene Ther ; 16(10): 786-93, 2009 Oct.

Article in En | MEDLINE | ID: mdl-19363465

Subject(s)

Burkitt Lymphoma/drug therapy; Peptide Nucleic Acids/pharmacology; Animals; Burkitt Lymphoma/genetics; Burkitt Lymphoma/metabolism; Cell Line, Tumor; Cell Transformation, Viral; Female; Humans; Luciferases, Firefly/biosynthesis; Luciferases, Firefly/genetics; Luminescent Measurements; Mice; Mice, SCID; Proto-Oncogene Proteins c-myc/biosynthesis; Proto-Oncogene Proteins c-myc/genetics; Transfection; Xenograft Model Antitumor Assays

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Burkitt Lymphoma / Peptide Nucleic Acids Limits: Animals / Female / Humans Language: En Journal: Cancer Gene Ther Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google